Course Director

Kimberly L. Blackwell, MD
Kimberly L. Blackwell, MD

Duke University Medical Center
Duke Cancer Institute
Durham, North Carolina

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CME
Credit Amount:0.5 Credits
Release Date:2016-Jul-21
Expiration Date:2017-Jul-20
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free of Charge

Activity Description and Educational Objectives

In this activity, a breast cancer expert discusses the neoadjuvant treatment of patients with HER2-positive breast cancer.

Upon completion of this activity, participants should be better able to:
  • Discuss the efficacy and safety results from neoadjuvant clinical trials evaluating current and emerging strategies for HER2-positive breast cancer
  • Summarize ongoing neoadjuvant clinical trials evaluating strategies for HER2-positive breast cancer
  • Select HER2-targeting agents and potential combination therapies for patients with HER2-positive breast cancer in the neoadjuvant setting according to latest evidence and guideline recommendations
  • Develop strategies for effective interdisciplinary collaboration to maximize patient outcomes in the neoadjuvant setting

Target Audience

This activity has been designed to meet the educational needs of oncologists, hematologist-oncologists, and other clinicians involved in the management of patients with breast cancer.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: July 21, 2016 - July 20, 2017
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME activity for any amount during the past 12 months.

Course Director
Kimberly L. Blackwell, MD
Professor of Medicine
Assistant Professor of Radiation Oncology
Duke University Medical Center
Duke Cancer Institute
Durham, North Carolina

Kimberly L. Blackwell, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for F. Hoffmann-La Roche Ltd; Incyte Corporation; and Sandoz.
Grant/Research Support from Celgene Corporation; Genentech, Inc.; Novartis Pharmaceuticals Corporation; and Pfizer Inc.
Advisory Board for Amgen Inc.; Celgene Corporation; Eli Lilly and Company; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Spectrum Pharmaceuticals, Inc.

Kimberly L. Blackwell, MD, does intend to discuss either non–FDA-approved or investigational use for the following products/devices: Targeted agents used as neoadjuvant therapy for HER2-positive breast cancer.

CME Reviewer
Vijaya R. Bhatt, MD
University of Nebraska Medical Center
Omaha, Nebraska

Vijaya R. Bhatt, MD, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director
Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education

Kathryn B. Charalambous, PhD, has no financial interests/relationships or affiliations in relation to this activity.

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from Genentech.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.

Copyright © 2000-2016, PeerView Press - Medical Education Resource

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.